Chapter 1 Executive Summary
- Market Outlook
- Scope of the Report
- Market Summary
Chapter 2 Market Overview
- Overview
- Porter’s Five Forces Analysis
- Bargaining Power of Buyers
- Bargaining Power of Suppliers
- Potential for New Entrants
- Threat of Substitutes
- Competitiveness in the Industry
Chapter 3 Market Dynamics
- Market Dynamics
- Market Drivers
- Market Restraints
- Market Opportunities
Chapter 4 Regulatory and Reimbursement Landscape
- Regulatory Scenario
- U.S.
- European Union
- Japan
- China
- Reimbursement Landscape
Chapter 5 Product Pipeline for Prefilled Syringes
Chapter 6 Market Segmentation Analysis
- Segmentation Breakdown
- Global Market for Prefilled Syringes, by Material
- Global Market Size and Forecast
- Glass Prefilled Syringes
- Plastic Prefilled Syringes
- Global Market for Prefilled Syringes, by Design
- Global Market Size and Forecast
- Single-Chamber Prefilled Syringes
- Dual-Chamber Prefilled Syringes
- Customized Prefilled Syringes
- Global Market for Prefilled Syringes, by Therapeutics
- Global Market Size and Forecast
- Small Molecules
- Monoclonal Antibodies
- Vaccines
- Other Therapeutics
- Global Market for Prefilled Syringes, by Application
- Global Market Size and Forecast
- Diabetes
- Cancer
- Infectious Diseases
- Other Applications
- Geographic Breakdown
- Global Market for Prefilled Syringes, by Region
- Global Market Size and Forecast
- North America
- Europe
- Asia-Pacific
- Rest of World
Chapter 7 Competitive Intelligence
Chapter 8 Sustainability in Prefilled Syringes: An ESG Perspective
- Introduction to ESG
- Sustainability in the Prefilled Syringes Market
- Environmental Impact
- Social Responsibility
- Governance
Chapter 9 Appendix: Global Prefilled Syringes Market
- Methodology
- Abbreviations
- Sources
- Company Profiles
- Arte Corp.
- Baxter
- BD
- F. Hoffmann-La Roche Ltd.
- Gerresheimer Ag
- Haselmeier
- Nipro
- SHL Medical Ag
- Stevanato Group
- Ypsomed
List of Tables
Summary Table: Global Market for Prefilled Syringes, by Material, Through 2029
Table 1: Porter’s Five Forces Analysis: Prefilled Syringes Market
Table 2: Global Diabetes Prevalence, Estimates and Projections, 2019-2045
Table 3: Global Prevalence of Multiple Sclerosis, by Region, 2013 and 2020
Table 4: Global Population Growth, by Age Group, Through 2050
Table 5: Product Pipeline for Prefilled Syringes
Table 6: Global Market for Prefilled Syringes, by Material, Through 2029
Table 7: Global Market for Glass Prefilled Syringes, by Region, Through 2029
Table 8: Global Market for Plastic Prefilled Syringes, by Region, Through 2029
Table 9: Global Market for Prefilled Syringes, by Design, Through 2029
Table 10: Global Market for Single-Chamber Prefilled Syringes, by Region, Through 2029
Table 11: Global Market for Dual-Chamber Prefilled Syringes, by Region, Through 2029
Table 12: Global Market for Customized Prefilled Syringes, by Region, Through 2029
Table 13: Global Market for Prefilled Syringes, by Therapeutics, Through 2029
Table 14: Global Market for Small Molecules, by Region, Through 2029
Table 15: Global Market for Monoclonal Antibodies, by Region, Through 2029
Table 16: Global Market for Vaccines, by Region, Through 2029
Table 17: Global Market for Other Therapeutics, by Region, Through 2029
Table 18: Global Market for Prefilled Syringes, by Application, Through 2029
Table 19: Global Market for Prefilled Syringes for Diabetes, by Region, Through 2029
Table 20: Global Market for Prefilled Syringes for Cancer, by Region, Through 2029
Table 21: Global HIV Epidemic, by Age Group, 2021
Table 22: Global Market for Prefilled Syringes for Infectious Diseases, by Region, Through 2029
Table 23: Global Market for Prefilled Syringes for Other Disease Treatments, by Region, Through 2029
Table 24: Global Market for Prefilled Syringes, by Region, Through 2029
Table 25: Diabetes Estimates in North America, by Country, 2000-2045
Table 26: Influenza Disease Burden in the U.S., by Age Group, 2019 and 2020 Flu Season
Table 27: North American Market for Prefilled Syringes, by Material, Through 2029
Table 28: North American Market for Prefilled Syringes, by Design, Through 2029
Table 29: North American Market for Prefilled Syringes, by Therapeutics, Through 2029
Table 30: North American Market for Prefilled Syringes, by Application, Through 2029
Table 31: North American Market for Prefilled Syringes, by Country, Through 2029
Table 32: Diabetes Estimates for 10 European Countries, 2000-2045
Table 33: European Market for Prefilled Syringes, by Material, Through 2029
Table 34: European Market for Prefilled Syringes, by Design, Through 2029
Table 35: European Market for Prefilled Syringes, by Therapeutics, Through 2029
Table 36: European Market for Prefilled Syringes, by Application, Through 2029
Table 37: European Market for Prefilled Syringes, by Country, Through 2029
Table 38: Diabetes Estimates for the Asia-Pacific Region, by Country, 2000-2045
Table 39: Asia-Pacific Market for Prefilled Syringes, by Material, Through 2029
Table 40: Asia-Pacific Market for Prefilled Syringes, by Design, Through 2029
Table 41: Asia-Pacific Market for Prefilled Syringes, by Therapeutics, Through 2029
Table 42: Asia-Pacific Market for Prefilled Syringes, by Application, Through 2029
Table 43: Asia-Pacific Market for Prefilled Syringes, by Country, Through 2029
Table 44: Diabetes Estimates in the RoW, by Country, 2000-2045
Table 45: Estimation of New Cancer Cases in Africa, by Cancer Type, 2020 and 2024
Table 46: RoW Market for Prefilled Syringes, by Material, Through 2029
Table 47: RoW Market for Prefilled Syringes, by Design, Through 2029
Table 48: RoW Market for Prefilled Syringes, by Therapeutics, Through 2029
Table 49: RoW Market for Prefilled Syringes, by Application, Through 2029
Table 50: RoW Market for Prefilled Syringes, by Sub-Region, Through 2029
Table 51: Abbreviations Used in this Report
Table 52: Report Sources
Table 53: ARTE Corp.: Company Snapshot
Table 54: ARTE Corp.: Product Portfolio
Table 55: Baxter: Company Snapshot
Table 56: Baxter: Financial Performance, FY 2022 and 2023
Table 57: Baxter: Product Portfolio
Table 58: BD: Company Snapshot
Table 59: BD: Financial Performance, FY 2022 and 2023
Table 60: BD: Product Portfolio
Table 61: BD: News/Key Developments, 2021 and 2022
Table 62: F. Hoffmann-La Roche Ltd.: Company Snapshot
Table 63: F. Hoffmann-La Roche Ltd.: Financial Performance, FY 2022 and 2023
Table 64: F. Hoffmann-La Roche Ltd: Product Portfolio
Table 65: Gerresheimer AG: Company Snapshot
Table 66: Gerresheimer AG: Financial Performance, FY 2022 and 2023
Table 67: Gerresheimer AG: Product Portfolio
Table 68: Haselmeier: Company Snapshot
Table 69: Haselmeier: Product Portfolio
Table 70: Haselmeier: News/Key Developments, 2024
Table 71: Nipro: Company Snapshot
Table 72: Nipro: Financial Performance, FY 2022 and 2023
Table 73: Nipro: Product Portfolio
Table 74: SHL Medical AG: Company Snapshot
Table 75: SHL Medical AG: Product Portfolio
Table 76: SHL Medical AG: News/Key Developments, 2024
Table 77: Stevanato Group: Company Snapshot
Table 78: Stevanato Group: Financial Performance, FY 2022 and 2023
Table 79: Stevanato Group: Product Portfolio
Table 80: Stevanato Group: News/Key Developments, 2023
Table 81: Ypsomed: Company Snapshot
Table 82: Ypsomed: Financial Performance, FY 2022 and 2023
Table 83: Ypsomed: Product Portfolio
List of Figures
Summary Figure: Global Market for Prefilled Syringes, by Material, 2021-2029
Figure 1: Prefilled Syringes: Market Dynamics
Figure 2: Distribution Share of the Five Most Frequent Cancers in Women, 2022
Figure 3: Distribution Share of the Five Most Frequent Cancers in Men, 2022
Figure 4: Share of Population Age 65 and Older in G7 Countries, 2021
Figure 5: Global Shares of Population 65 and Older, by Region, 2016 and 2050
Figure 6: Global Market for Prefilled Syringes, by Material, 2021-2029
Figure 7: Global Market for Prefilled Syringes, by Design, 2021-2029
Figure 8: Global Market for Prefilled Syringes, by Therapeutics, 2021-2029
Figure 9: Global Market for Prefilled Syringes, by Application, 2021-2029
Figure 10: Global Market for Prefilled Syringes, by Region, 2021-2029
Figure 11: Distribution Share of Cancer Diagnoses in Europe, by Gender, 2020
Figure 12: Global Market Shares for Prefilled Syringes, by Company, 2023
Figure 13: Pillars of ESG
Figure 14: Advantages of ESG for Companies
Figure 15: Global ESG-Adoption Level Across All Industries, 2021 and 2022
Figure 16: Baxter: Revenue Share, by Country/Region, FY 2023
Figure 17: BD: Revenue Share, by Business Unit, FY 2023
Figure 18: BD: Revenue Share, by Country/Region, FY 2023
Figure 19: F. Hoffmann-La Roche Ltd.: Revenue Share, by Business Unit, FY 2023
Figure 20: F. Hoffmann-La Roche Ltd.: Revenue Share, by Country/Region, FY 2023
Figure 21: Gerresheimer AG: Revenue Share, by Business Unit, FY 2023
Figure 22: Gerresheimer AG: Revenue Share, by Country/Region, FY 2023
Figure 23: Nipro: Revenue Share, by Business Unit, FY 2023
Figure 24: Nipro: Revenue Share, by Country/Region, FY 2023
Figure 25: Stevanato Group: Revenue Share, by Business Unit, FY 2023
Figure 26: Stevanato Group: Revenue Share, by Country/Region, FY 2023
Figure 27: Ypsomed: Revenue Share, by Business Unit, FY 2023
Figure 28: Ypsomed: Revenue Share, by Country/Region, FY 2023
